Published
Tuberculosis: A Review on Its Novel Advancement on Its Elimination
, , , , , , , ,
Published in January 2026 Issue 01 (Vol. 14, Issue 1, 2026)

Keywords
Abstract
ABSTRACTTuberculosis, caused by Mycobacterium tuberculosis, remains a global public health issue. Latent TB is an airborne chronic disease; 46% of the world’s population is thought to be infected with LTB. It is most prevalent in the lungs (pulmonary TB) but can also affect other organs (extrapulmonary TB). Immunocompromised individuals, such as HIV-positive individuals, are at much greater risk for active TB.M. tuberculosis is an aerobic, non-motile rod whose high levels of lipids make it difficult to diagnose and thus avoid the immune system. It is transmitted via aerosol droplets, where the bacteria infect the lungs and can then remain in granulomas for years. One of the major obstacles to TB control is the advent of drug-resistant strains, such as multidrug-resistant TB, which are not effective when compared to the best first-line agents. Toxic treatment, lack of quality drugs, or improper medicine contribute to its growth. High levels of diagnostic variability hinder progress, and an estimated 4 million undiagnosed cases a year fuel transmission. WGS can be applied in various ways, but its use has a limited impact. A financial constraint also severely limits TB control efforts. Future strategies to combat TB will include better vaccines, new drugs and rapid point-of-care diagnostics. Controlling the disease requires focused screening practices, diagnosis intervention, adequate funding, and drug resistance, along with ethical principles of informed consent and patient agency in research and care.Keywords: Mycobacterium tuberculosis, drug-resistant, novel drug discovery, TB preventive therapy and screening practices
Citations & discovery
Explore citations to this article and find it in scholarly databases.
Checking citation sources…
Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.
Authors (9)
Dr.M.Shamshath Begum
View all publications →Dr.Deepa Natarajan
View all publications →Cathrina.A
View all publications →Kokila.R
View all publications →Dhanusri.J
View all publications →Hyrun Laafiya.J.A
View all publications →Prince.Pinegah.K
View all publications →Mageshwari.S
View all publications →Rupavathi Christina.J
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
January 2026 Issue 01 (Vol. 14, Issue 1, 2026)Article Impact
Views:3,909
Downloads:869
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Begum, D., Natarajan, D., Cathrina.A, Kokila.R, Dhanusri.J, Laafiya.J.A, H., Prince.Pinegah.K, Mageshwari.S, & Christina.J, R. (2026). Tuberculosis: A Review on Its Novel Advancement on Its Elimination. American Journal of Pharmacy and Health Research, 14(1), 1-16. https://doi.org/10.5281/zenodo.19219381
Article Actions
More from this Issue
More by These Authors
The Histological Effect of Aqueous Extract of Ginger on the Liver of Adult Wistar Rats.
2014 • Vol. 2, Issue 12
Read more →
